换一批Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.
第一作者：
Sharon,Barrans
第一单位：
Haematology Malignancy Diagnostic Service (HMDS), St James's Institute of Oncology, Leeds, United Kingdom. sharonb@hmds.org.uk
作者：
医学主题词
成年人(Adult);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);泼尼松(Prednisone);预后(Prognosis);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc);易位, 遗传(Translocation, Genetic);长春新碱(Vincristine)
DOI
10.1200/JCO.2009.26.3947
PMID
20498406
发布时间
2022-03-16
- 浏览46
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
